Modern management of chronic myelogenous leukemia (CML)

Cancer Invest. 1988;6(6):737-42. doi: 10.3109/07357908809078041.
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Blast Crisis
  • Bone Marrow Transplantation
  • Graft vs Host Disease / etiology
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / mortality
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / therapy*
  • Splenectomy

Substances

  • Antineoplastic Agents